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Experimental muscle pain inhibits corticomotor excitability (CE) of upper limb muscles. It is unknown if this inhibition affects
overlapping muscle representations within the primary motor cortex to the same degree. This study explored CE changes of the
first dorsal interosseus (FDI) and extensor carpi radialis (ECR) muscles in response to muscle pain. Participants (n = 13)
attended two sessions (≥48 hours in-between). Hypertonic saline was injected in the ECR (session one) or the FDI (session two)
muscle. CE, assessed by transcranial magnetic stimulation (TMS) motor-evoked potentials (MEPs), was recorded at baseline,
during pain, and twenty minutes postinjection together with pain intensity ratings. Pain intensity ratings did not differ between
the two pain sites (p = 0 19). In response to FDI muscle pain, the MEPs of the FDI muscle were reduced at 2 and 4min
postinjection (p ≤ 0 03), but not after ECR muscle pain. No significant MEP change was detected for the ECR muscle (p = 0 62).
No associations between MEPs and pain intensity were found (p > 0 2). The present results indicate that the output from
overlapping cortical representations of two muscles differentially adapts to acute muscle pain.
1. Introduction
Musculoskeletal pain disorders are leading cause of disability
in the world [1]. This underscores the importance of tar-
geting underlying mechanisms in the transition from
acute-to-chronic musculoskeletal pain. Nonetheless, the
mechanisms remain poorly understood and therefore pose
a challenge to effectively treat [2]. It has been proposed
that central nervous system neuroplasticity may play a piv-
otal role in the persistence of pain [3] as seen in, for
example, low-back [4] and phantom-limb pain patients
[5]. In this respect, it is well established that acute muscle
pain alters the function of human sensorimotor cortices,
often reflected in a moderate-to-strong reduction in sensory
and primary motor cortex (MI) excitability, as assessed by
somatosensory-evoked potentials or motor-evoked poten-
tials (MEPs), respectively [6]. A current opinion is that
following an injury to a segment of the body, the net
corticomotor excitability representing the injured segment
reduces [7]. The reduction in corticomotor excitability may
be a protective mechanism that serves to prevent further
damage by inhibiting motor output [7]. Experimental muscle
pain studies have indeed demonstrated impaired motor con-
trol in response to experimental pain [8, 9]. Additionally,
acute muscle pain can induce a strong inhibition of cortico-
motor excitability of the muscle in pain that persists, despite
no ongoing pain, for up to 30min [10–13]. Such neuroplastic
pain-related modulations suggest that corticomotor inhibi-
tion serves to protect a painful limb even after pain has
dissipated, but also that several muscles may be affected by
this inhibition [10, 14].
The body divisions are generally represented in specific
areas of the MI giving rise to a topography [15]. However,
it is evident that MI topography is not bound to a strict rep-
resentation of each individual muscle, and this has been
shown in detail for the hand [16]. The upper limb muscle
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representations within the MI are relatively well defined but
also show strong overlap between muscles such as the first
dorsal interosseous (FDI) and extensor carpi radialis (ECR)
muscles [17], which can be further expanded with training
[18] or smudged during chronic pain conditions [19]. For
instance, a study exploring the representation of upper limb
musculature in elite volleyball players demonstrated a greater
overlap of the medial deltoid and the ECR muscles, which is
activated when performing a volleyball spike, when com-
pared to elite endurance athletes (runners) [18].
What remains unknown is whether the presence of acute
muscle pain in one muscle simultaneously inhibits cortico-
motor excitability of overlapping muscle representations
within the MI. Therefore, the current study was aimed at
exploring the impact of experimentally induced muscle pain
on corticomotor excitability in muscles with known overlap-
ping MI representations, specifically the ECR and the FDI
muscles. It was hypothesized that the corticomotor excitabil-
ity and cortical representations of FDI and ECR muscles
would (1) reduce in response to experimental pain induced
in the ECR or FDI muscle, and (2) that MI inhibition would
outlast the perception of pain, as earlier shown, up to 10min
post pain.
2. Methods and Materials
2.1. Participants. The effect size (standardized mean differ-
ence) of acute experimental pain on corticomotor excitability
reduction at rest was based on a recent meta-analysis and sys-
tematic review (0.52 (−0.01, 1.06)) [6] and used to estimate
the sample size of the current study.
Eighteen healthy, right-handed participants (mean age
± SD: 27.8± 6.0; 18–45 years; 7 women) with no recent
history of upper limb (acute/chronic pain), musculoskele-
tal, or neurological conditions were included. Prior to
inclusion, all participants were screened using the transcra-
nial magnetic stimulation (TMS) screening questionnaire
[20, 21]. All participants were right-handed as assessed by
the Edinburgh Handedness Inventory (mean laterality quo-
tient± SD: 0.90± 0.13) [22].
The study was approved by the local ethics committee
(VN-20170006) and conducted in accordance with the
Declaration of Helsinki. Written informed consent was
obtained prior to participation.
2.2. Experimental Design. The experiment was performed
over two sessions separated by at least 48 hours where the
corticomotor excitability of the ECR and FDI motor repre-
sentations were assessed in response to experimental ECR
muscle pain or FDI muscle pain, one pain condition per
session (Figure 1). Participants were seated comfortably
in a chair and their arm rested in an approximate 45°
angle flexion. Corticomotor excitability was assessed by
MEPs evoked by TMS and recorded at baseline. Experi-
mental muscle pain was then induced by injection of
hypertonic saline into the ECR or the FDI muscle. Imme-
diately after the injection, participants were asked to rate
the pain intensity, followed by pain intensity rating every
minute for the next 10min (during pain). Concurrently,
10 TMS pulses were delivered every minute for 10min.
Following the 10min of TMS and pain intensity rating, a
10min break ensued. During this, the participants were
instructed to remain relaxed. Twenty minutes postinjection,
corticomotor excitability was assessed again.
2.3. Transcranial Magnetic Stimulation. The TMS methods
are described in accordance with the recent guidelines on
TMS methodology reporting [23]. Monophasic TMS pulses
were delivered with a magnetic stimulator (Magstim BiStim2,
Magstim Company, UK), using a focal figure-of-eight coil
(D702, Magstim Company, UK). Stimulations were per-
formed with the coil handle pointing backwards and laterally
at a 45° angle to the sagittal plane, inducing a posterior-
anterior directed current, to elicit MEPs from the ECR and
FDI muscles. All TMS pulses were delivered with an inter-
stimulus interval (ISI) of 5–7 seconds.
To standardize orientation and location of TMS pulse
delivery, the participants were fitted with a swimming cap
containing a predefined grid (1× 1 cm squares) orientated
to the vertex (0, 0). This was used to determine the optimal
scalp position (hotspot) and resting motor threshold
(RMT) for either the ECR or FDI muscle. The hotspot for
the ECR or FDI muscle, dependent on session (i.e., ECR
hotspot for the ECR muscle pain session and vice versa for
FDI muscle pain), was determined using 50% of maximum
stimulator output and was defined as the site that yielded
the most consistent and highest peak-to-peak amplitude
TMS-MEPs in three trials. Subsequently, the RMT at
the hotspot was determined based on the stimulus inten-
sity needed to evoke MEPs≥ 50μV in the ECR or FDI
muscle in five out of 10 trials with the muscles at rest
[24]. The stimulation intensity was set to 120%×RMT
for the remaining of the experiment. To ensure that the
baseline TMS-MEPs were sufficient to capture the corti-
comotor excitability, 2× 10 TMS-MEPs with 30 s break
in-between were recorded during the ECR muscle pain
session in four participants and all participants for the
FDI muscle pain session. The remaining baseline averages
are based on 10 TMS-MEPs.
2.4. Recording of Motor-Evoked Potentials. Surface electro-
myography (EMG) was recorded from the muscle belly of
the ECR and FDI muscles with bipolar Ag/AgCl electrodes
(Neuroline 720, Ambu® A/S, DK) placed with an approxi-
mate 20mm interelectrode distance. The reference electrodes
were placed at the styloideus processus (FDI) or the olecra-
non (ECR), both of the ulna. The EMG data were sampled
at 4 kHz, preamplified (1000x gain), and analogue bandpass
filtered at 5Hz–1 kHz. EMG data were digitized by a 16-
bit data acquisition card (National Instruments, NI6122;
voltage: 10V), and peak-to-peak TMS-MEPs were shown
online by custom-made LabVIEW software (Mr. Kick III,
SMI, Aalborg University).
2.5. Experimental Muscle Pain. The sites of injections were
determined by palpation of the contracted ECR or FDI mus-
cle, and the skin was cleaned with alcohol. A bolus injection
of hypertonic saline (5.8% NaCl) was administered to either
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the ECR or the FDI muscle using a 1mL syringe with a
disposable needle (27G). The volume of the bolus was
0.5mL for the ECR muscle [25] and 0.2mL for the FDI mus-
cle [10]. To assess the intensity of pain in response to the
hypertonic saline injection, the participants were asked to
rate the pain intensity on a 0–10 numerical rating scale
(NRS) (“0” representing “no pain” and “10” representing
“worst imaginable pain”) immediately after injection, every
minute during pain, and at 20min postinjection.
2.6. Statistical Analysis. Data are presented as mean MEPs
± standard error of the mean (SEM) unless otherwise stated.
Peak-to-peak values of raw MEPs for the ECR and FDI mus-
cles were extracted for both sessions and used for analysis.
Each MEP was assessed offline for any motor activity imme-
diately prior to the stimulation, and if present (≥40μV),
excluded from the analysis (a total of 1.5% of all MEPs was
rejected based on this premise). MEPs recorded during pain
were averaged based on 20 stimulations (i.e., every two min
during pain) to reflect corticomotor excitability change over
time, yielding a total of seven time points (baseline, five time
points during pain, and 20min postinjection). For each time
point, MEPs for the FDI and ECR muscles were subjected to
an analysis for normality (Shapiro-Wilk test for normality)
and log transformed (residuals were retested for normal dis-
tribution). MEPs from each muscle were analysed using a
two-way repeated measures’ analysis of variance (RM
ANOVA) (within-subjects’ factors: pain site [ECR pain or
FDI pain]× time [baseline, five time points during pain,
and 20min postinjection]). Bonferroni-corrected post hoc
analyses were performed as appropriate. NRS scores of the
pain intensity were averaged in epochs of 2min and sub-
jected to a two-way RM ANOVA (within-subjects’ factors:
pain site [ECR pain or FDI pain]× time [baseline, five time
points during pain, and 20min postinjection]). To clarify if
changes in corticomotor excitability and peak pain intensity
were associated, the relative change in MEPs at peak pain
compared to baseline (MEPpeak pain/MEPbaseline) was calcu-
lated for each participant and correlated with the corre-
sponding peak pain intensity. Correlation analysis was
performed using Spearman’s ranked correlation analysis.
Statistical analyses were carried out in Statistical Package
for Social Sciences (SPSS; version 24, IBM). A p value< 0.05
was considered statistically significant.
3. Results
3.1. Participants and TMS Parameters.Out of the 18 included
participants, 14 returned for the FDI pain session (age: 29.6
± 5.4, 18–45 years). Data from one participant was removed
from analysis due to technical issues evoking TMS-MEPs
during the FDI pain session. Therefore, the analysis was
performed on 13 participants (5 women).
The RMT of the ECR muscle was 43.5± 9.6% of the max-
imum stimulator output and 40.3± 8.1% for the FDI muscle.
In the FDI pain session, which included two blocks of 10
TMS-MEPs, no significant difference was found between
the first and second blocks of ten recorded ECR and FDI
MEPs, p = 0 34 and p = 0 49, respectively, paired sample
t-test. These results indicate that the recording of 10
MEPs was sufficient to capture the corticomotor excitability
at baseline. The amplitude of the baseline MEPs did not
significantly differ between sessions for either the ECR or
the FDI (both p > 0 17, paired sample t-tests). Furthermore,
the average distance from vertex for the ECR hotspot
was 1.5 cm (anterior-posterior) and 5.1 cm (mediolateral),
whereas it was 1.7 cm (anterior-posterior) and 5.1 cm (med-
iolateral) for the FDI hotspot.
3.2. Pain Intensity for the ECR Injection versus the FDI
Injection. The NRS scores of the pain intensity following
the ECR and FDI muscle injections of hypertonic saline
were not significantly different (F(1.91, 22.88) = 1.49, p =
0 19, η2partial = 0.11) although there was an overall time
effect (F(2.44, 29.32) = 76.45, p < 0 005, η2partial = 0.86)
demonstrating peak pain intensity at 2min compared to
immediately postinjection (p = 0 001) (Figure 2).
3.3. Corticomotor Excitability for the ECR and FDI Muscle.
The two-way RM ANOVA for FDI MEPs showed an
interaction between pain site and time (F(3.002,
36.03) = 4.29, p = 0 01, η2partial = 0.26). Post hoc analysis
revealed a time effect for the FDI muscle, during FDI pain
(F(2.45, 29.35) = 4.11, p = 0 02, η2partial = 0.26), but not dur-
ing ECR pain (F(6, 72) = 0.81, p = 0 57, η2partial = 0.06).
Pairwise comparisons for the FDI MEPs showed that
corticomotor excitability of the FDI was inhibited after
2min (p = 0 01), 4min (p = 0 029), and trending inhibition
at 6min (p = 0 074) compared to baseline (Figure 3).
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Figure 1: Experimental design. Participants joined two experimental sessions separated by at least 48 hours. In session one, experimental pain
was induced by injection of hypertonic saline into the ECR muscle and in session two the FDI muscle was injected. The procedure for both
sessions was identical with the only difference being the optimal scalp position determined for either the ECR or FDI muscle. ECR: extensor
carpi radialis; FDI: first dorsal interosseus; RMT: resting motor threshold; TMS: transcranial magnetic stimulation.
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Individually, clear inhibition was found in 11 participants,
whereas 2 participants exerted less inhibition or no change.
For the ECR MEPs, the two-way RM ANOVA did not
reveal a significant interaction (F(6, 72) = 0.74, p = 0 62,
η2partial = 0.06; Figure 4), but a significant main effect of pain
site (F(1, 12) = 6.13, p = 0 03, η2partial = 0.34).
3.4. Correlation Analyses. No significant associations were
found between percentage MEP changes and peak pain
intensity, for ECR MEPs during ECR pain (rho=−0.07, p =
0 83) (Figure 5(a)) or FDI pain (rho=0.21, p = 0 49)
(Figure 5(b)). Similarly, the FDI MEP percentage changes
from baseline were not significantly associated with peak
pain intensity during ECR pain (rho=−0.06, p = 0 84)
(Figure 5(c)) or FDI pain (rho= 0.20, p = 0 51) (Figure 5(d)).
4. Discussion
The present findings show that the corticomotor excitability
of the FDI muscle was reduced in response to hypertonic
saline-induced FDI pain but not with ECR pain. In addition,
corticomotor excitability of the ECR muscle did not change
in response to hypertonic saline-induced ECR or FDI pain.
These findings are contrary to the present hypothesis on
simultaneous inhibition of both muscles. Further, an unex-
pected finding was that corticomotor excitability of the FDI
muscle returned to baseline within 10min after hypertonic
saline injection, whereas previous studies have shown pro-
longed reduction of MEPs.
4.1. Reduction of Corticomotor Excitability in Response to
Acute Muscle Pain. In this study, the FDI corticomotor excit-
ability reduction in response to hypertonic saline-induced
muscle pain is in line with previous studies which demon-
strated a moderate-to-strong reduction in net corticomotor
excitability during muscle pain [10, 11, 26]. Reduction of
the FDI corticomotor excitability in association with pain
has also been demonstrated following CO2 laser stimuli to
the dorsum of the right hand [27] and capsaicin cream to
the skin overlying the FDI [28]. Further, noxious heat applied
to the lateral edge of the hand reduced the MEPs of FDI and
opponens pollicis muscles [29]. Altogether, these studies
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Figure 2: Mean (±SEM) NRS scores of the pain intensity ratings
over time for hypertonic saline injection into the ECR (filled
circles) or FDI (open circles) muscle. No significant difference was
found in the two pain profiles over time. ECR: extensor carpi
radialis; FDI: first dorsal interosseus; NRS: numerical rating scale;
Im. after: immediately after injection of hypertonic saline.
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Figure 3: Mean (±SEM) MEPs of the FDI muscle following
hypertonic saline injection into the ECR muscle (solid bars) and
FDI muscle (open bars). Significantly reduced MEP as compared
to baseline is illustrated (∗p < 0 05; Bonferroni corrected). FDI:
first dorsal interosseus; TMS: transcranial magnetic stimulation;
MEPs: motor-evoked potentials.
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Figure 4: Mean (±SEM) MEPs of the ECR muscle following
hypertonic saline injection into the ECR muscle (solid bars) and
FDI muscle (open bars). Neither injection of hypertonic saline
into the ECR muscle nor FDI muscle significantly altered the
corticomotor excitability of the ECR muscle, at any time point
compared to baseline. FDI: first dorsal interosseus; TMS:
transcranial magnetic stimulation; MEPs: motor-evoked potentials.
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support that noxious stimulation of the skin, regardless of
modality, and muscle pain reduces corticomotor excitability
of the FDI. The mechanisms underlying reduction of cortico-
motor excitability are still elusive. Peripheral M-wave ampli-
tudes remain stable during pain in the tibialis anterior
muscle, suggesting a central effect of pain on muscle activity
[30]. Studies investigating spinal excitability, as measured by
monosynaptic reflex activity (e.g., the Hoffmann reflex or
cervicomedullary-evoked potentials), have reported incon-
clusive results and seem largely dependent on the muscle
(distal versus proximal) [10, 26, 31]. These findings support
the notion that acute experimental muscle pain predomi-
nantly causes inhibition at the cortical level during pain,
without excluding spinal influences. Further, earlier evidence
has demonstrated changes in gamma-aminobutyric acid and
glutamate mediated inhibitory and facilitatory intracortical
circuits in response to acute muscle pain, as assessed by
paired-pulse TMS paradigms of hand musculature [14, 32].
However, studies have also reported that other muscles may
react differently to pain. For instance, no change in cortico-
motor excitability of the masseter muscle was found follow-
ing injection of hypertonic saline or application of capsaicin
cream to the cheek [33]. Painful mechanical pressure
increased corticomotor excitability of the brachioradialis
muscle [34]. These findings, together with the lack of signif-
icant inhibition of the ECR corticomotor excitability in the
current study, suggest that pain does not solely exert inhibi-
tory effects on MEPs. The question then becomes why
noxious stimulation of the FDI or hand, but not forearm
musculature, exerts inhibitory effects on corticomotor excit-
ability? It could be argued that the larger amplitudes of the
FDI MEPs recorded in the current study offers a larger
opportunity for reduction, whereas the lower amplitudes of
the ECR MEPs may mask inhibitory effects on corticomotor
excitability. Indeed, predetermined 500μV ECR MEPs at
baseline have been shown to capture strong inhibition at pain
resolve after hypertonic saline-induced pain [25]. Whether
stimulus intensity is a key aspect of capturing ECR inhibition
remains unknown, since this has not been investigated sys-
tematically. In respect to the current findings, baseline values
for both the FDI and ECR muscles are in line with previously
published literature, when stimulating at 120% RMT [14, 35],
and as such is comparable in terms of corticomotor excitabil-
ity changes. However, it cannot excludes that a similar
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Figure 5: Correlations between percentage change in MEP magnitude versus peak pain intensity. No significant associations were found
between percentage MEP changes from baseline at peak pain, with peak pain intensity for either the (a) ECR MEPs during ECR pain,
(b) ECR MEPs during FDI pain, (c) FDI MEPs during ECR pain, or (d) FDI MEPs during FDI pain.
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pattern of ECR inhibition would occur if the intensity had
been set to produce a predetermined MEP output at baseline,
and needs further exploration.
4.2. No Simultaneous Pain Inhibition of Corticomotor
Excitability of Hand and Forearm Muscles. This study dem-
onstrates that the corticomotor excitability of two muscles
adapts differently to the same experimental muscle pain
model. The differential adaptation of corticomotor excitabil-
ity of the FDI muscle versus the ECR muscle was contrary to
expectations, given prior evidence which suggest that homo-
topic hand muscles (FDI and abductor digiti minimi) exhibit
the same inhibition pattern during pain, independent of site
of injection [10]. Furthermore, hypertonic saline injection
into the flexor carpi radialis (FCR) produced a similar inhibi-
tion of FCR MEPs as seen for the hand muscles [10]. Most
recently, this characteristic reduction was shown for the
ECR corticomotor excitability over time in response to
hypertonic saline [25]. Conversely, skin pain evoked by cap-
saicin cream application to the dorsum of the hand resulted
in no significant reductions of the FCR or the flexor digi-
torum superficialis corticomotor excitability [36]. Together
with the current findings, this challenges our understanding
of how pain may influence corticomotor excitability. It is
possible that MI inhibition is only one of many patterns of
change that can occur in response to acute muscle pain.
Whether these patterns of corticomotor excitability are a
direct consequence of the pain or are also influenced by the
function of the muscles involved [37] needs to be clarified.
The present results show differential responses to muscle
pain, supporting that different response patterns exist. Fur-
ther research is warranted to fully appreciate the extent of
possible different patterns and/or how muscle function
influences corticomotor excitability changes in response to
acute experimental muscle pain.
4.3. Time Course of MI Corticomotor Excitability in Response
to Acute Muscle Pain. One common finding for most studies
investigating pain and its effects on corticomotor excitability
is that not only does pain affect the MEPs short term, but also
outlasts the perception of pain [10, 11, 26]. This may indicate
that corticomotor excitability changes are only partially
driven by noxious input, such as that caused by hypertonic
saline. In contrast and controversial to the earlier findings
of a lasting inhibition of the corticomotor excitability [6],
the results of the current study suggest that the reduction of
FDI MEPs is susceptible to modulation during the acute pain
period. It could be argued that other factors such as saliency
of pain decreases over time and therefore allows a return-to-
baseline for the motor output, however, since the participants
still perceived pain after 10min, this is unlikely to be the only
explaining factor. Further, since the participants were asked
to verbally rate their pain intensity during the pain and
TMS application, both motor activation due to speech [38]
together with attentional factors [39] may have had an
impact on corticomotor excitability. Nonetheless, it is impor-
tant to note that participants always rated in-between two
TMS stimulations (both muscles), but we cannot rule out
possible carryover effects. Future studies may explore the
impact of speech (pain rating) or attention towards pain
intensity while temporally profiling corticomotor excitability
during pain, to understand its potential contribution to the
current findings.
4.4. Differential Modulation of Corticomotor Excitability and
Its Relation to Functional Outcomes.Most studies have inves-
tigated isolated muscles (most commonly effector muscles)
in pain, when assessing functional changes, such as motor
control performance or learning. For instance, during train-
ing of a novel tongue-protrusion task, it was shown that cap-
saicin cream applied to the tongue reduced the gains in
excitability of the tongue MI that would otherwise occur
during training in a pain-free state, however, gains in perfor-
mance were still evident [9]. A later study corroborated that
pain can interfere with corticomotor excitability increases,
but not necessarily acquisition of the motor skill [40]. It has
further been reported that if pain affects acquisition of move-
ment patterns during training, these altered movement
patterns may persist 24 hours later [41]. Additionally, neck
training in the presence of acute hypertonic saline-induced
pain may induce long-lasting inhibition of corticomotor
excitability [42]. Conversely, other studies have reported
that different topical pain paradigms such as capsaicin
[40, 43–45] or heat [46] do not alter acquisition during
performance of different motor tasks, but retention may
be enhanced [45]. As such, a large body of contrasting evi-
dence is available, and the interaction between pain and
motor acquisition/retention remains controversial. Further
research is needed to understand the impact of different
effector muscles in relation to pain and its effects on
motor learning outcomes.
In support of the current findings, differences in cortico-
motor excitability responses between the FDI and ECR have
been described previously but in relation to voluntary con-
tractions [47] and median nerve stimulation [48]. For
instance, voluntary contractions spanning 0–100% MVC
revealed a large difference in the level of contraction needed
for saturation of the MEPs due to TMS [47]. This finding
was ascribed to differences in corticomotoneuronal connec-
tions between distal hand musculature and proximal forearm
musculature [47]. This also suggests that hand musculature is
more readily susceptible to neuroplastic adaptations to exter-
nal stimuli than that of more proximal muscles such as the
ECR muscle. These lines of evidence suggest that (1) cortico-
motor excitability changes may play a pivotal role during
motor learning and (2) the corticomotor inhibition may
serve to prevent acquisition of harmful movement patterns
[7] but the overall response could be dependent on the func-
tion of each muscle [49]. Since few studies have investigated
the possibility of preventing or reversing corticomotor inhi-
bition [25] and the functional outcome of this, the potential
of improving motor relearning paradigms remains unknown.
4.5. Limitations. In this study, only one optimal scalp posi-
tion or the hotspot was tested in each session as we aimed
to understand the change in cortical excitability throughout
pain duration. The pain duration in this study was relatively
short thus limiting the feasibility to assess cortical excitability
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of the ECR and FDI at each respective hotspot. The benefit of
using an acute experimental pain model such as hypertonic
saline injections is that it allows for standardization of time
and location of the pain [8, 50–52]. The disadvantage is the
short-lasting pain evoked by hypertonic saline which limits
our ability to infer about clinical relevance. In general, small
sample sizes compromise generalizability and should be con-
sidered. Since no control group (i.e., isotonic saline injection)
was enrolled, it cannot be excluded that the reduction in FDI
corticomotor excitability is due to a placebo effect. Nonethe-
less, earlier evidence suggests that a nociceptive input (such
as the one experienced from hypertonic saline injection) is
pivotal for the reduction in corticomotor excitability [10,
12, 26]. Further, MEP amplitudes are reliable as a repeated
measure [26, 53], thereby excluding time as an explanatory
factor for MEP reduction. Of note, we opted not to include
measures of spinal motoneuronal excitability, since this was
outside the scope of the current study. Therefore, we are
not able to rule out a spinal influence on the corticospinal
excitability reduction (denoted as corticomotor excitability)
in response to hypertonic saline. Nonetheless, studies investi-
gating H-/F-wave amplitudes in response to pain have shown
that spinal motoneuronal excitability does not change [28] or
is reduced after peak pain [10], during acute experimental
pain.
5. Conclusions
The current study demonstrates that two topographically
overlapping muscle representations within the MI adapt
differently to hypertonic saline-induced muscle pain. This
suggests a nonuniform effect of pain on corticomotor excit-
ability across a distal and a proximal muscle. The lack of
prolonged inhibition of FDI corticomotor excitability
warrants further investigations on how different methodolo-
gies may provide insight into the neuroplasticity of cortico-
motor excitability.
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